BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barnes EL, Kochar B, Long MD, Kappelman MD, Martin CF, Korzenik JR, Crockett SD. Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database. Inflamm Bowel Dis 2017;23:875-81. [PMID: 28426473 DOI: 10.1097/MIB.0000000000001121] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 9.2] [Reference Citation Analysis]
Number Citing Articles
1 Moon SJ, Lee YC, Kim TJ, Kim K, Son HJ. Effects of temperature, weather, seasons, atmosphere, and climate on the exacerbation of inflammatory bowel diseases: A systematic review and meta-analysis. PLoS One 2022;17:e0279277. [PMID: 36538512 DOI: 10.1371/journal.pone.0279277] [Reference Citation Analysis]
2 Sheehan JL, Jacob J, Berinstein EM, Greene-Higgs L, Steiner CA, Berry SK, Shannon C, Cohen-Mekelburg SA, Higgins PDR, Berinstein JA. The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Inflamm Bowel Dis 2022;28:1904-14. [PMID: 35230420 DOI: 10.1093/ibd/izac021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Di Candido F. Quality of Life in Inflammatory Bowel Diseases (IBDs) Patients after Surgery. Rev Recent Clin Trials 2022;17:227-39. [PMID: 35959618 DOI: 10.2174/1574887117666220811143426] [Reference Citation Analysis]
4 Wen T, Faye AS, Lee KE, Friedman AM, Wright JD, Lebwohl B, Colombel JF. Risk of Postpartum Flare Hospitalizations in Patients with Inflammatory Bowel Disease Persists After Six Months. Dig Dis Sci 2022;67:4278-86. [PMID: 33932199 DOI: 10.1007/s10620-021-06999-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hill E, Nguyen NH, Qian AS, Patel S, Chen PL, Tse CS, Singh S. Impact of Comorbid Psychiatric Disorders on Healthcare Utilization in Patients with Inflammatory Bowel Disease: A Nationally Representative Cohort Study. Dig Dis Sci 2022;67:4373-81. [PMID: 35503486 DOI: 10.1007/s10620-022-07505-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Barnes EL. Treating IBD? Don't Forget that Mental Health Matters. Dig Dis Sci 2022;67:4321-3. [PMID: 35503485 DOI: 10.1007/s10620-022-07510-y] [Reference Citation Analysis]
7 Mikocka-Walus A, van Tilburg MAL. Preventing suicide in people with inflammatory bowel disease. J Psychosom Res 2022;161:111001. [PMID: 36030592 DOI: 10.1016/j.jpsychores.2022.111001] [Reference Citation Analysis]
8 Glynn H, Mikocka-Walus A, Knowles SR. Editorial: Hospitalization Experiences and Post-traumatic Stress in Inflammatory Bowel Disease: Opportunities for Change. Inflamm Bowel Dis 2022:izac166. [PMID: 35894682 DOI: 10.1093/ibd/izac166] [Reference Citation Analysis]
9 Nguyen NH, Zhang X, Long MD, Sandborn WJ, Kappelman MD, Singh S. Patient-Reported Outcomes and Risk of Hospitalization and Readmission in Patients with Inflammatory Bowel Diseases. Dig Dis Sci 2022;67:2039-48. [PMID: 34110539 DOI: 10.1007/s10620-021-07082-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Dahiya DS, Perisetti A, Kichloo A, Singh A, Goyal H, Rotundo L, Vennikandam M, Shaka H, Singh G, Singh J, Pisipati S, Al-Haddad M, Sanaka MR, Inamdar S. Increasing thirty-day readmissions of Crohn’s disease and ulcerative colitis in the United States: A national dilemma. World J Gastrointest Pathophysiol 2022; 13(3): 85-95 [DOI: 10.4291/wjgp.v13.i3.85] [Reference Citation Analysis]
11 Davies L, Schubert A, Guthrie R, Oravetz P. Reducing Readmission Penalty and Cost Risks Through Comprehensive Care Transition and Accurate Documentation. Optimizing Widely Reported Hospital Quality and Safety Grades 2022. [DOI: 10.1007/978-3-031-04141-9_38] [Reference Citation Analysis]
12 Ghahramani S, Tamartash Z, Sayari M, Vahedi H, Karimian F, Heydari S, Bagheri Lankarani K. Risk Factors Affecting 90-day Readmission of Patients with Inflammatory Bowel Disease. Middle East J Dig Dis 2022;14:34-43. [PMID: 36619729 DOI: 10.34172/mejdd.2022.253] [Reference Citation Analysis]
13 Hudson JL, Barnes EL. Quality of Care in the Management of Hospitalized Patients with Inflammatory Bowel Disease. Management of Inpatient Inflammatory Bowel Disease 2022. [DOI: 10.1007/978-1-0716-1987-2_10] [Reference Citation Analysis]
14 Kim DJ, Tischler EH, Kong RM, Nehme F, Dolphin EJ, Ho ES, Lescaille Y, Naziri Q. Crohn's disease in total knee arthroplasty patients correlates with increased rates of 90-day and overall postoperative complications and readmissions. Knee 2022;34:238-45. [PMID: 35030505 DOI: 10.1016/j.knee.2021.12.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Faye AS, Wen T, Soroush A, Ananthakrishnan AN, Ungaro R, Lawlor G, Attenello FJ, Mack WJ, Colombel JF, Lebwohl B. Increasing Prevalence of Frailty and Its Association with Readmission and Mortality Among Hospitalized Patients with IBD. Dig Dis Sci 2021;66:4178-90. [PMID: 33385264 DOI: 10.1007/s10620-020-06746-w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
16 Soriano CR, Powell CR, Chiorean MV, Simianu VV. Role of hospitalization for inflammatory bowel disease in the post-biologic era. World J Clin Cases 2021; 9(26): 7632-7642 [PMID: 34621815 DOI: 10.12998/wjcc.v9.i26.7632] [Reference Citation Analysis]
17 Fairbrass KM, Gracie DJ, Ford AC. Longitudinal follow-up study: effect of psychological co-morbidity on the prognosis of inflammatory bowel disease. Aliment Pharmacol Ther 2021;54:441-50. [PMID: 34114664 DOI: 10.1111/apt.16454] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
18 Click B, Barnes EL, Cohen BL, Sands BE, Hanson JS, Regueiro M, Rubin DT, Dubinsky MC, Gazis DR, Dalfonso L, Hildebrand JS, Crawford JM, Long MD. Methodology and Initial Results From a Real-World Observational Cohort of Patients With Inflammatory Bowel Disease: TARGET-IBD. Crohn's & Colitis 360 2021;3. [DOI: 10.1093/crocol/otab023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Weissman S, Sharma, S, Fung BM, Aziz M, Sciarra M, Swaminath A, Feuerstein JD. Increased Mortality and Healthcare Costs Upon Hospital Readmissions of Ulcerative Colitis Flares: A Large Population-Based Cohort Study. Crohn's & Colitis 360 2021;3:otab029. [DOI: 10.1093/crocol/otab029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Xu F, Wheaton AG, Barbour KE, Liu Y, Greenlund KJ. Trends and Outcomes of Hip Fracture Hospitalization Among Medicare Beneficiaries with Inflammatory Bowel Disease, 2000-2017. Dig Dis Sci 2021;66:1818-28. [PMID: 32700169 DOI: 10.1007/s10620-020-06476-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Cai W, Cagan A, He Z, Ananthakrishnan AN. A Phenome-Wide Analysis of Healthcare Costs Associated with Inflammatory Bowel Diseases. Dig Dis Sci 2021;66:760-7. [PMID: 32436120 DOI: 10.1007/s10620-020-06329-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
22 Lee D, Keller MS, Fridman R, Lee J, Pevnick JM. Association between operational positive depression symptom screen scores on hospital admission and 30-day readmissions. Gen Hosp Psychiatry 2021;70:38-43. [PMID: 33713863 DOI: 10.1016/j.genhosppsych.2021.02.003] [Reference Citation Analysis]
23 Barnes EL, Loftus EV Jr, Kappelman MD. Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases. Gastroenterology 2021;160:677-89. [PMID: 33098884 DOI: 10.1053/j.gastro.2020.08.064] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 17.5] [Reference Citation Analysis]
24 Shaftel KA, Cole TS, Little AS. National trends in hospital readmission following transsphenoidal surgery for pituitary lesions. Pituitary 2020;23:79-91. [PMID: 31728907 DOI: 10.1007/s11102-019-01007-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
25 Szigethy E, Murphy SM, Ehrlich OG, Engel-Nitz NM, Heller CA, Henrichsen K, Lawton R, Meadows P, Allen JI. Mental Health Costs of Inflammatory Bowel Diseases. Inflamm Bowel Dis 2021;27:40-8. [PMID: 32095835 DOI: 10.1093/ibd/izaa030] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
26 Barnes EL. Standardizing Healthcare Delivery to Reduce Utilization, the Potential of Evidence-Based Care Pathways. Crohn's & Colitis 360 2020;2. [DOI: 10.1093/crocol/otaa081] [Reference Citation Analysis]
27 Nguyen NH, Koola J, Dulai PS, Prokop LJ, Sandborn WJ, Singh S. Rate of Risk Factors for and Interventions to Reduce Hospital Readmission in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2020;18:1939-1948.e7. [PMID: 31470176 DOI: 10.1016/j.cgh.2019.08.042] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
28 Krohn K, Pfeifer M, Manzey P, Koletzko S. Chronisch entzündliche Darmerkrankungen – die biopsychosoziale Realität im Kindes- und Jugendalter. Bundesgesundheitsbl 2020;63:839-845. [DOI: 10.1007/s00103-020-03166-z] [Reference Citation Analysis]
29 Charilaou P, Mohapatra S, Joshi T, Devani K, Gadiparthi C, Pitchumoni CS, Goldstein D. Opioid Use Disorder Increases 30-Day Readmission Risk in Inflammatory Bowel Disease Hospitalizations: a Nationwide Matched Analysis. J Crohns Colitis 2020;14:636-45. [PMID: 31804682 DOI: 10.1093/ecco-jcc/jjz198] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
30 Faye AS, Wen T, Ananthakrishnan AN, Lichtiger S, Kaplan GG, Friedman AM, Lawlor G, Wright JD, Attenello FJ, Mack WJ, Lebwohl B. Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2020;18:1133-1141.e3. [PMID: 31336196 DOI: 10.1016/j.cgh.2019.07.028] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 9.7] [Reference Citation Analysis]
31 Weaver E, Szigethy E. Managing Pain and Psychosocial Care in IBD: a Primer for the Practicing Gastroenterologist. Curr Gastroenterol Rep 2020;22:20. [PMID: 32185521 DOI: 10.1007/s11894-020-0757-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
32 Mikocka-Walus A, Ford AC, Drossman DA. Antidepressants in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2020;17:184-92. [PMID: 32071420 DOI: 10.1038/s41575-019-0259-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
33 Barnes EL. Patterns of Opioid Use Among Patients With Inflammatory Bowel Disease: Do We Need Better Disease Control or Multidisciplinary Interventions? Crohn's & Colitis 360 2020;2. [DOI: 10.1093/crocol/otaa010] [Reference Citation Analysis]
34 Santiago M, Magro F, Correia L, Portela F, Ministro P, Lago P, Trindade E, Dias CC. Rehospitalization rates, costs, and risk factors for inflammatory bowel disease: a 16-year nationwide study. Therap Adv Gastroenterol 2020;13:175628482092383. [DOI: 10.1177/1756284820923836] [Reference Citation Analysis]
35 Asscher VER, Lee-Kong FVY, Kort ED, van Deudekom FJ, Mooijaart SP, Maljaars PWJ. Systematic Review: Components of a Comprehensive Geriatric Assessment in Inflammatory Bowel Disease-A Potentially Promising but Often Neglected Risk Stratification. J Crohns Colitis 2019;13:1418-32. [PMID: 31002331 DOI: 10.1093/ecco-jcc/jjz082] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
36 Mikocka-Walus A, Massuger W, Knowles SR, Moore GT, Buckton S, Connell W, Pavli P, Raven L, Andrews JM. Psychological distress is highly prevalent in inflammatory bowel disease: A survey of psychological needs and attitudes. JGH Open 2020;4:166-71. [PMID: 32280760 DOI: 10.1002/jgh3.12236] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
37 Kinnucan J, Binion D, Cross R, Evans E, Harlen K, Matarese L, Mullins A, O'Neal B, Reiss M, Scott FI, Weaver A, Rosenberg J. Inflammatory Bowel Disease Care Referral Pathway. Gastroenterology 2019;157:242-254.e6. [PMID: 30980795 DOI: 10.1053/j.gastro.2019.03.064] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
38 George LA, Martin B, Gupta N, Shastri N, Venu M, Naik AS. Predicting 30-Day Readmission Rate in Inflammatory Bowel Disease Patients: Performance of LACE Index. Crohn's & Colitis 360 2019;1:otz007. [DOI: 10.1093/crocol/otz007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
39 Schmidt T, Feagins LA. How Can We Improve to Keep Our Patients Out of the Hospital? Inflamm Bowel Dis 2019;25:980-6. [PMID: 30380035 DOI: 10.1093/ibd/izy335] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Ahmed Z, Sarvepalli S, Garber A, Regueiro M, Rizk MK. Value-Based Health Care in Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:958-68. [PMID: 30418558 DOI: 10.1093/ibd/izy340] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
41 Kruger AJ, Hinton A, Afzali A. Index Severity Score and Early Readmission Predicts Increased Mortality in Ulcerative Colitis Patients. Inflamm Bowel Dis 2019;25:894-901. [PMID: 30247551 DOI: 10.1093/ibd/izy297] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
42 Moulton CD, Pavlidis P, Norton C, Norton S, Pariante C, Hayee B, Powell N. Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation? Clin Exp Immunol 2019;197:308-18. [PMID: 30762873 DOI: 10.1111/cei.13276] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 11.0] [Reference Citation Analysis]
43 Okafor PN, Nnadi AK, Okoli O, Huang AE, Nwaiwu O. Same- vs Different-Hospital Readmissions in Patients With Cirrhosis After Hospital Discharge. Am J Gastroenterol 2019;114:464-71. [PMID: 30676364 DOI: 10.14309/ajg.0000000000000050] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
44 Cohen-Mekelburg S, Rosenblatt R, Gold S, Shen N, Fortune B, Waljee AK, Saini S, Scherl E, Burakoff R, Unruh M. Fragmented Care is Prevalent Among Inflammatory Bowel Disease Readmissions and is Associated With Worse Outcomes. Am J Gastroenterol 2019;114:276-90. [PMID: 30420634 DOI: 10.1038/s41395-018-0417-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
45 Cohen-Mekelburg S, Rosenblatt R, Gold S, Burakoff R, Waljee AK, Saini S, Schackman BR, Scherl E, Crawford C. The Impact of Opioid Epidemic Trends on Hospitalised Inflammatory Bowel Disease Patients. J Crohns Colitis 2018;12:1030-5. [PMID: 29741667 DOI: 10.1093/ecco-jcc/jjy062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
46 Suarez Ferrer C, Poza Cordon J, Cerpa Arencibia A, Sanchez Azofra M, Martin Arranz E, Jacuotot Herranz M, Gomez Senent S, Martin Arranz MD. Hospitalization in inflammatory bowel disease: Current perspective. Gastroenterología y Hepatología (English Edition) 2018;41:350-352. [DOI: 10.1016/j.gastre.2018.05.014] [Reference Citation Analysis]
47 Kedia S, Limdi JK, Ahuja V. Management of inflammatory bowel disease in older persons: evolving paradigms. Intest Res 2018;16:194-208. [PMID: 29743832 DOI: 10.5217/ir.2018.16.2.194] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
48 Suarez Ferrer C, Poza Cordon J, Cerpa Arencibia A, Sanchez Azofra M, Martin Arranz E, Jacuotot Herranz M, Gomez Senent S, Martin Arranz MD. Perspectiva actual hospitalization in inflammatory bowel disease: Current perspective. Gastroenterol Hepatol 2018;41:350-2. [PMID: 29636279 DOI: 10.1016/j.gastrohep.2018.01.009] [Reference Citation Analysis]
49 Micic D, Gaetano JN, Rubin JN, Cohen RD, Sakuraba A, Rubin DT, Pekow J. Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease. PLoS One 2017;12:e0182900. [PMID: 28837634 DOI: 10.1371/journal.pone.0182900] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]